Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Amputations in Sickle Cell Disease: Case Series and Literature Review.

Maximo C, Olalla Saad ST, Thome E, Queiroz AM, Lobo C, Ballas SK.

Hemoglobin. 2016 Jun;40(3):150-5. doi: 10.3109/03630269.2016.1167736.

PMID:
27117565
2.

Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression.

Olenscki Gilli SC, Pericole FV, Benites BD, Sippert EÂ, Castilho LM, Addas-Carvalho M, Olalla Saad ST.

Exp Hematol. 2016 Jul;44(7):583-9. doi: 10.1016/j.exphem.2016.03.008.

PMID:
27026283
3.

Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.

Scopim-Ribeiro R, Machado-Neto JA, de Melo Campos P, Niemann FS, Lorand-Metze I, Costa FF, Olalla Saad ST, Traina F.

Diagn Pathol. 2016 Mar 16;11:28. doi: 10.1186/s13000-016-0476-4.

4.

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.

de Melo Campos P, Machado-Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, da Silva Souza Duarte A, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Olalla Saad ST, Traina F.

Oncotarget. 2016 Feb 9;7(6):6948-59. doi: 10.18632/oncotarget.6851.

5.

Interactions of sickle red blood cells with neutrophils are stabilized on endothelial cell layers.

Dominical VM, Vital DM, Garrido VT, Silveira AA, Olalla-Saad ST, Costa FF, Conran N.

Blood Cells Mol Dis. 2016 Jan;56(1):38-40. doi: 10.1016/j.bcmd.2015.10.006. No abstract available.

PMID:
26603722
6.

Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.

Ribeiro TB, Duarte AS, Longhini AL, Pradella F, Farias AS, Luzo AC, Oliveira AL, Olalla Saad ST.

Sci Rep. 2015 Nov 9;5:16167. doi: 10.1038/srep16167.

7.

Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.

Manzini BM, da Silva Santos Duarte A, Sankaramanivel S, Ramos AL, Latuf-Filho P, Escanhoela C, Kharmandayan P, Olalla Saad ST, Boin I, Malheiros Luzo ÂC.

Cytotherapy. 2015 Aug;17(8):1052-65. doi: 10.1016/j.jcyt.2015.04.010.

PMID:
26139545
8.

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms.

Machado-Neto JA, de Melo Campos P, de Albuquerque DM, Costa FF, Lorand-Metze I, Olalla Saad ST, Traina F.

Rev Bras Hematol Hemoter. 2015 May-Jun;37(3):211-4. doi: 10.1016/j.bjhh.2015.03.012. No abstract available.

9.

Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Lopes FC, Traina F, Almeida CB, Leonardo FC, Franco-Penteado CF, Garrido VT, Colella MP, Soares R, Olalla-Saad ST, Costa FF, Conran N.

Haematologica. 2015 Jun;100(6):730-9. doi: 10.3324/haematol.2014.119727.

10.

Elevated hypercoagulability markers in hemoglobin SC disease.

Colella MP, de Paula EV, Machado-Neto JA, Conran N, Annichino-Bizzacchi JM, Costa FF, Olalla Saad ST, Traina F.

Haematologica. 2015 Apr;100(4):466-71. doi: 10.3324/haematol.2014.114587.

11.

ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.

Machado-Neto JA, Lazarini M, Favaro P, de Melo Campos P, Scopim-Ribeiro R, Franchi Junior GC, Nowill AE, Lima PR, Costa FF, Benichou S, Olalla Saad ST, Traina F.

Biochim Biophys Acta. 2015 Mar;1853(3):583-93. doi: 10.1016/j.bbamcr.2014.12.012.

12.

Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else.

de Melo Campos P, Traina F, Lorand-Metze I, Olalla Saad ST.

Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):442-4. doi: 10.1016/j.bjhh.2014.07.005.

13.

Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells.

Bernusso VA, Machado-Neto JA, Pericole FV, Vieira KP, Duarte AS, Traina F, Hansen MD, Olalla Saad ST, Barcellos KS.

Biochim Biophys Acta. 2015 Feb;1853(2):388-95. doi: 10.1016/j.bbamcr.2014.11.008.

14.

Umbilical cord blood CD34(+) stem cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapy.

Pereira-Cunha FG, Duarte AS, Reis-Alves SC, Olalla Saad ST, Metze K, Lorand-Metze I, Luzo ÂC.

Vox Sang. 2015 Jan;108(1):72-81. doi: 10.1111/vox.12199.

PMID:
25333825
15.

Mesenchymal stromal cells from adipose tissue attached to suture material enhance the closure of enterocutaneous fistulas in a rat model.

Volpe BB, Santos Duarte Ada S, Ribeiro TB, Stocchero I, Kharmandayan P, Olalla Saad ST, Bustorff-Silva JM, Malheiros Luzo AC.

Cytotherapy. 2014 Dec;16(12):1709-19. doi: 10.1016/j.jcyt.2014.08.004.

PMID:
25305734
16.

Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412.

de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, Traina F.

Leuk Res. 2014 Oct;38(10):1245-51. doi: 10.1016/j.leukres.2014.07.010.

17.

YAP1 expression in myelodysplastic syndromes and acute leukemias.

Machado-Neto JA, de Melo Campos P, Olalla Saad ST, Traina F.

Leuk Lymphoma. 2014 Oct;55(10):2413-5. doi: 10.3109/10428194.2014.891028. No abstract available.

PMID:
24605912
18.

Endothelial activation by platelets from sickle cell anemia patients.

Proença-Ferreira R, Brugnerotto AF, Garrido VT, Dominical VM, Vital DM, Ribeiro Mde F, dos Santos ME, Traina F, Olalla-Saad ST, Costa FF, Conran N.

PLoS One. 2014 Feb 13;9(2):e89012. doi: 10.1371/journal.pone.0089012.

19.

Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.

Pallis FR, Conran N, Fertrin KY, Olalla Saad ST, Costa FF, Franco-Penteado CF.

Br J Haematol. 2014 Jan;164(2):286-95. doi: 10.1111/bjh.12628.

PMID:
24383847
20.

Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells.

Machado-Neto JA, de Melo Campos P, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Olalla Saad ST, Traina F.

Leuk Res. 2014 Feb;38(2):251-7. doi: 10.1016/j.leukres.2013.11.013.

PMID:
24355524
Items per page

Supplemental Content

Loading ...
Support Center